Rare diseases
Investigational molecules
Locations
Back to Slovakia78 clinical trials in Trnava, Slovakia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa
SlovakiaStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
SlovakiaEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
SlovakiaStudy on Ganaxolone for Patients with Refractory Status Epilepticus
SlovakiaStudy on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid
SlovakiaStudy of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for non-small cell lung cancer, advanced breast cancer, and head and neck cancer. Studies are evaluating new combination therapies and investigating targeted treatments for patients with specific biomarkers.
Multiple ongoing trials investigating treatments for relapsing multiple sclerosis. Research includes comparative studies of new therapeutic agents and evaluation of treatment effectiveness in patients transitioning between therapies.
Research focusing on atherosclerotic cardiovascular disease and stroke prevention. Trials are evaluating new treatments for reducing major cardiovascular events and managing complications in high-risk patients.
Studies examining treatments for hidradenitis suppurativa, chronic plaque psoriasis, and vitiligo. Research includes both adult and pediatric populations, with a focus on novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
